Name | SB209670 |
---|---|
Synonyms | SB-209670 |
Description | SB-209670 is an extremely potent and highly specific non-peptide, subnanomolar endothelin (ET) receptor antagonist. SB 209670 selectively inhibits binding of 125I-labeled ET-1 to cloned human ET receptor subtypes ETA and ETB (Ki=0.2 and 18 nM, respectively). SB 209670 produces a dose-dependent reduction in blood pressure in hypertensive rats, protects from ischemia-induced neuronal degeneration in a gerbil stroke model, and attenuates neointima formation following rat carotid artery balloon angioplasty[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C29H28O9 |
---|---|
Molecular Weight | 520.53 |